The problem of delusional ugliness: Is it really body dysmorphic disorder?

References

• Albertini RS, Phillips KA. Thirty-three cases of body dysmorphic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38: 453–459
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders4th ed. Text revision. American Psychiatric Press, Washington, DC 2000
   Google Scholar
• Appelbaum PS, Robbins PC, Roth LH. Dimensional approach to delusions: Comparison across types and diagnoses. Am J Psychiatry 1999; 156: 1938–1943
   PubMed Web of Science ®Google Scholar
• Appelbaum PS, Robbins PC, Vesselinov R. Persistence and stability of delusions over time. Compr Psychiatry 2004; 45: 317–324
   PubMed Web of Science ®Google Scholar
• Baker PB, Cook BL, Winokur G. Delusional infestation. The interface of delusions and hallucinations. Psychiatr Clin North Am 1995; 18: 345–361
   PubMedGoogle Scholar
• Berrios GE, Luque R. Cotard's syndrome: Analysis of 100 cases. Acta Psychiatr Scand 1995; 91: 185–188
   PubMed Web of Science ®Google Scholar
• Bystritsky A, Ackerman DL, Rosen RM, Vapnik T, Gorbis E, Maidment KM, et al. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: A placebo-controlled trial. J Clin Psychiatry 2004; 65: 565–568
   PubMed Web of Science ®Google Scholar
• Carey P, Seedat S, Warwick J, van Heerden B, Stein DJ. SPECT imaging of body dysmorphic disorder. J Neuropsychiatry Clin Neurosci 2004; 16: 357–359
   PubMed Web of Science ®Google Scholar
• Cutting J. Principles of psychopathology. Oxford University Press, Oxford 1997
   Google Scholar
• de Leon J, Bott A, Simpson GM. Dysmorphophobia: Body dysmorphic disorder or delusional disorder, somatic subtype?. Compr Psychiatry 1989; 30: 457–472
   PubMedGoogle Scholar
• Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65: 1040–1048
   PubMed Web of Science ®Google Scholar
• Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown Assessment of Beliefs Scale: Reliability and validity. Am J Psychiatry 1998; 155: 102–108
   PubMed Web of Science ®Google Scholar
• Fontenelle LF, Mendlowicz MV, Mussi TC, Marques C, Versiani M. The man with the purple nostrils: A case of rhinotrichotillomania secondary to body dysmorphic disorder. Acta Psychiatr Scand 2002; 106: 464–466
   PubMed Web of Science ®Google Scholar
• Garety PA, Hemsley DR. Characteristics of delusional experience. Eur Arch Psychiatry Neurol Sci 1987; 236: 294–298
   PubMedGoogle Scholar
• Grant JE. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: A case report. J Clin Psychiatry 2001; 62: 297–298
   PubMed Web of Science ®Google Scholar
• Hamann K, Avnstorp C. Delusions of infestation treated by pimozide: A double-blind crossover clinical study. Acta Dermatol Venereol 1982; 62: 55–58
   PubMed Web of Science ®Google Scholar
• Hayashi H, Oshino S, Ishikawa J, Kawakatsu S, Otani K. Paroxetine treatment of delusional disorder, somatic type. Hum Psychopharmacol 2004; 19: 351–352
   PubMed Web of Science ®Google Scholar
• Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: Selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999; 56: 1033–1039
   PubMed Web of Science ®Google Scholar
• Insel TR, Akiskal HS. Obsessive-compulsive disorder with psychotic features: A phenomenologic analysis. Am J Psychiatry 1986; 143: 1527–1533
   PubMed Web of Science ®Google Scholar
• Jaspers K. General Psychopathology. Manchester University Press, Manchester 1963
   Google Scholar
• Kendler KS, Glazer WM, Morgenstern H. Dimensions of delusional experience. Am J Psychiatry 1983; 140: 466–469
   PubMed Web of Science ®Google Scholar
• Marbach JJ. Phantom bite syndrome. Am J Psychiatry 1978; 135: 476–479
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994; 51: 302–308
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57: 794–801
   PubMed Web of Science ®Google Scholar
• McElroy SL, Phillips KA, Keck PE, Jr, Hudson JI, Pope HG, Jr. Body dysmorphic disorder: Does it have a psychotic subtype?. J Clin Psychiatry 1993; 54: 389–395
   PubMed Web of Science ®Google Scholar
• Modell S, Kurtz G, Hoff P. Dysmorphophobia: Differential-diagnostic aspects. Psychopathology 1996; 29: 126–130
   PubMedGoogle Scholar
• Munro A. Delusional disorder: Paranoia and related illnesses. Cambridge University Press, Cambridge 1999
   Google Scholar
• Munro A, Mok H. An overview of treatment in paranoia/delusional disorder. Can J Psychiatry 1995; 40: 616–622
   PubMedGoogle Scholar
• Mullen R. Delusions: The continuum versus category debate. Aust NZ J Psychiatry 2003; 37: 505–511
   PubMed Web of Science ®Google Scholar
• Opjordsmoen S. The duration criteria of delusional disorder in modern classification. Psychopathology 1993; 26: 85–89
   PubMedGoogle Scholar
• O'Sullivan RL, Phillips KA, Keuthen NJ, Wilhelm S. Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. Psychosomatics 1999; 40: 79–81
   PubMed Web of Science ®Google Scholar
• Ota M, Mizukami K, Katano T, Sato S, Takeda T, Asada T. A case of delusional disorder, somatic type with remarkable improvement of clinical symptoms and single photon emission computed tomograpy findings following modified electroconvulsive therapy. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 881–884
   PubMed Web of Science ®Google Scholar
• Oulis P, Mamounas J, Hatzimanolis J, Christodoulou GN. Clinical dimensions of delusional beliefs: A factor-analytic study. Psychopathology. 2000; 33: 81–85
   PubMedGoogle Scholar
• Phillips KA. Body dysmorphic disorder: The distress of imagined ugliness. Am J Psychiatry 1991; 148: 1138–1149
   PubMed Web of Science ®Google Scholar
• Phillips KA. Psychosis in body dysmorphic disorder. J Psychiatr Res 2004; 38: 63–72
   PubMed Web of Science ®Google Scholar
• Phillips KA. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry 2005; 162: 377–379
   PubMed Web of Science ®Google Scholar
• Phillips KA, Taub SL. Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull 1995; 31: 279–288
   PubMedGoogle Scholar
• Phillips KA, McElroy SL, Keck PE, Jr, Pope HG, Jr, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993; 150: 302–308
   PubMed Web of Science ®Google Scholar
• Phillips KA, McElroy SL, Keck PE, Jr, Hudson JI, Pope HG, Jr. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994; 30: 179–186
   PubMedGoogle Scholar
• Phillips KA, Albertini RS, Siniscalchi JM, Khan A, Robinson M. Effectiveness of pharmacotherapy for body dysmorphic disorder: A chart-review study. J Clin Psychiatry 2001; 62: 721–727
   PubMed Web of Science ®Google Scholar
• Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 2002; 59: 381–388
   PubMed Web of Science ®Google Scholar
• Phillips KA, Price LH, Greenberg BD, Rasmussen SA. Should the DSM diagnostic grouping be changed?. Advancing DSM: Dilemmas in psychiatric diagnosis, KA Phillips, MB First, HA Pincus. American Psychiatric Press, Washington, DC 2003; 57–83
   Google Scholar
• Pryse-Phillips W. An olfactory reference syndrome. Acta Psychiatr Scand 1971; 47: 484–509
   PubMed Web of Science ®Google Scholar
• Riding J, Munro A. Pimozide in the treatment of monosymptomatic hypochondriacal psychosis. Acta Psychiatr Scand 1975; 52: 23–30
   PubMedGoogle Scholar
• Sondheimer A. Clomipramine treatment of delusional disorder-somatic type. J Am Acad Child Adolesc Psychiatry 1988; 27: 188–192
   PubMedGoogle Scholar
• Stein DJ, Le Roux L, Bouwer C, Van Heerden B. Is olfactory reference syndrome an obsessive-compulsive spectrum disorder? Two cases and a discussion. J Neuropsychiatry Clin Neurosci 1998; 10: 96–99
   PubMed Web of Science ®Google Scholar
• Swerdlow NR. Blurry Spectrum Disorders. 2000. In:. Maj M, Sartorius N, Okasha A, Zohar J, editors. Obsessive-Compulsive Disorder. Chichester: John Wiley & Sons Ltd. pp 235–238.
   Google Scholar
• Torres AR, Tiosso AM, Gambarini-Zen AM. [Um caso de delírio de infestação parasitária tratado com clomipramina]. Revista ABP-APAL 1996; 18: 29–34
   Google Scholar
• Ungvari G, Vladar K. Pimozide treatment for delusion of infestation. Act Nerv Super (Praha) 1986; 28: 103–107
   PubMedGoogle Scholar
• Wada T, Kawakatsu S, Komatani A, Okuyama N, Otani K. Possible association between delusional disorder, somatic type and reduced regional cerebral blood flow. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23: 353–357
   PubMed Web of Science ®Google Scholar
• Wurtz R. Psychiatric diseases presenting as infectious diseases. Clin Infect Dis 1998; 26: 924–932
   PubMedGoogle Scholar